Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-24-040439
Filing Date
2024-10-08
Accepted
2024-10-08 16:10:16
Documents
1
Period of Report
2024-08-09

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 5049
  Complete submission text file 0001493152-24-040439.txt   6643
Mailing Address 245 MAIN STREET SUITE 204 CHESTER NJ 07930
Business Address 1200 ROUTE 22 EAST BRIDGEWATER NJ 08807 302-743-2995
Tharimmune, Inc. (Issuer) CIK: 0001861657 (see all company filings)

EIN.: 842642541 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1200 ROUTE 22 EAST SUITE 2000 BRIDGEWATER NJ 08807
Business Address
Appajosyula Sireesh (Reporting) CIK: 0001901565 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41210 | Film No.: 241360426